Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma
Conclusion:
Differences in the intestinal microbiomes and their functions may influence the incidence of diarrhea during lenvatinib treatment.
Source: Digestive Diseases - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Study